“Since we began leveraging Stratasys 3D printing technology, we’ve experienced faster turnarounds, better capabilities and a vibrant, growing business.”
"The use of 3D printing in healthcare has represented a fundamental milestone compared to the use of 2D images, and now Stratasys’ 3D printing technology is taking a further step forward."
"We wanted to make sure we had a partner with multiple technologies, capable of supporting us in the future as well, and helping us achieve our goal of creating an economically sustainable product."
“The time savings are enormous and it is no exaggeration to say that we’re comparing something that would take up to five or six weeks, versus having something in our hands within just a few days.”
“Before, it would have taken us upwards of a week to model this part. With KeyShot and the J55, you send the file to print, and the next morning it’s done.”
“We try to get a broader group together and quickly create designs that we pin up on a board.”
"With CAD, you have ability to infinitely zoom in and pan out, and you lose a sense of scale. You can lose the sense that you’re designing something that’s meant to be held in the hand.”
“Product design is about putting the users first – we’re trying to create something that makes their life easier, and a little bit more seamless.”
“Having a full color 3D model in the middle of the design process really changes the game.”
“Using VeroClear™, we can express even the gentlest curves and bends without leaving any fine grains.”
“We are no longer forced to decline orders due to capacity limitations as we now have the capability and bandwidth to accept each of them and deliver them within shorter lead times.”
“We use 3D printing to improve patient outcomes on any scale. And when there's not a solution to a patient-specific problem or a process that needs to be improved, 3D printing has been a game changer.”
“We put out a survey to all the technologists that used it in training and 85 percent of them said they preferred having a contrast-filled phantom to work with.”
"For resin-based parts, the trend is in favor of the Objet Connex, which now accounts for more than one third of production."
"This model was really very helpful for us to envision how to reach the tumour."